Come up with a name for your new list and we'll add to it:
ATreaon raised a round of funding on October 26, 2011. Investors include
Morningside Group (晨兴集团).
ATreaon is a pharmaceutical company that has designed a molecule based on the growth factor proganulin that could help treat rheumatoid arthritis and other autoimmune diseases.…